EXPERIENCE OF A LARGE ACADEMIC CF CENTER WITH LUMACAFTOR/IVACAFTOR

被引：0
|
作者：
Walker, S. D. [1 ]
Henry, B. [1 ]
Sueblinvong, V [1 ]
Hunt, W. R. [1 ]
机构：
[1] Emory Univ, Med, Atlanta, GA 30322 USA
来源：
PEDIATRIC PULMONOLOGY | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
291
引用
下载
收藏
页码：302 / 302
页数：1
相关论文
共 50 条
  • [21] Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis
    Emma D. Deeks
    Drugs, 2016, 76 : 1191 - 1201
  • [22] Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis
    Deeks, Emma D.
    DRUGS, 2016, 76 (12) : 1191 - 1201
  • [23] Bridging for lung transplantation with lumacaftor/ivacaftor
    Pedersen, Soren Sperling
    Jensen-Fangel, Soren
    Jeppesen, Majbritt
    BREATHE, 2018, 14 (02) : E68 - E71
  • [24] Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor
    Singh, Sachinkumar B.
    McLearn-Montz, Amanda J.
    Milavetz, Francesca
    Gates, Levi K.
    Fox, Christopher
    Murry, Logan T.
    Sabus, Ashley
    Porterfield, Harry S.
    Fischer, Anthony J.
    PEDIATRIC PULMONOLOGY, 2019, 54 (08) : 1200 - 1208
  • [25] The safety of lumacaftor and ivacaftor for the treatment of cystic fibrosis
    Guevara, Maria Talamo
    McColley, Susanna A.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (11) : 1305 - 1311
  • [26] PREDICTIVE BIOMARKERS FOR LUMACAFTOR/IVACAFTOR CLINICAL RESPONSE
    Masson, A.
    Pranke, I
    Schneider, E.
    Hatton, A.
    Nguyen-Khoa, T.
    Lebourgeois, M.
    Edelman, A.
    Sermet, I
    PEDIATRIC PULMONOLOGY, 2018, 53 : 251 - 251
  • [27] THE EFFECT OF IVACAFTOR/LUMACAFTOR ON GASTROINTESTINAL FUNCTION IN SUBJECTS WITH CF HOMOZYGOUS FOR F508DEL MUTATION
    de Monestrol, I
    Miroslav, V
    Wilschanski, M.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S132 - S133
  • [28] Metabolomic responses to lumacaftor/ivacaftor in cystic fibrosis
    Kopp, Benjamin T.
    McCulloch, Scott
    Shrestha, Chandra L.
    Zhang, Shuzhong
    Sarzynski, Lisa
    Woodley, Frederick W.
    Hayes, Don, Jr.
    PEDIATRIC PULMONOLOGY, 2018, 53 (05) : 583 - 591
  • [29] SINGLE-CENTER RETROSPECTIVE ANALYSIS OF THE EFFECT OF LUMACAFTOR/IVACAFTOR AND ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON BIOMARKERS OF LIVER DISEASE IN CYSTIC FIBROSIS
    Fuchs, Yonathan
    Levitte, Steven
    Wise, Russell
    Sellers, Zachary
    HEPATOLOGY, 2021, 74 : 1178A - 1179A
  • [30] Predictive factors for lumacaftor/ivacaftor clinical response
    Masson, Alexandra
    Schneider-Futschik, Elena K.
    Baatallah, Nesrine
    Thao Nguyen-Khoa
    Girodon, Emmanuelle
    Hatton, Aurelie
    Flament, Thomas
    Le Bourgeois, Muriel
    Chedevergne, Frederique
    Bailly, Celine
    Kyrilli, Sylvia
    Achimastos, Diane
    Hinzpeter, Alexandre
    Edelman, Aleksander
    Sermet-Gaudelus, Isabelle
    JOURNAL OF CYSTIC FIBROSIS, 2019, 18 (03) : 368 - 374
12345